THOMAS FRANK E

CIK 00012426166 companiesBALA CYNWYD, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001242616

Recent Transactions

50 trades

Purchase
Larimar Therapeutics, Inc.$LRMR
Common Stock
2026-02-27$5.00/sh+5,000→ 7,000 total
Award
Spero Therapeutics, Inc.$SPRO
Common Stock
2025-06-12+20,000→ 75,000 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2025-05-13+19,000→ 19,000 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2024-05-29+19,000→ 19,000 total
Award
Spero Therapeutics, Inc.$SPRO
Common Stock
2024-05-29+20,000→ 55,000 total
Purchase
Larimar Therapeutics, Inc.$LRMR
Common Stock
2024-02-14$11.00/sh+2,000→ 2,000 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2024-01-24−75,000→ 0 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2024-01-24−335,000→ 0 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2024-01-24−27,730→ 0 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2024-01-24−457,800→ 0 total
Disposition to Issuer
Orchard Therapeutics plc
Ordinary Shares
2024-01-24−92,081→ 0 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2024-01-24−99,980→ 0 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2024-01-24−405,590→ 0 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2024-01-24−149,990→ 0 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2024-01-24−309,990→ 0 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2024-01-24−199,990→ 0 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2024-01-24−179,390→ 0 total
Award
Spero Therapeutics, Inc.$SPRO
Common Stock
2023-10-05+20,000→ 35,000 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2023-05-09+8,300→ 8,300 total
Exercise/Conversion
Orchard Therapeutics plc
Stock Option (Right to Buy)
2023-03-10−20,000→ 335,000 total
Exercise/Conversion
Orchard Therapeutics plc
Ordinary Shares
2023-03-10$0.46/sh+20,000→ 92,081 total
Award
Orchard Therapeutics plc
Stock Option (Right to Buy)
2023-03-01+179,400→ 179,400 total
Award
Orchard Therapeutics plc
Stock Option (Right to Buy)
2023-03-01+405,600→ 405,600 total
Exercise/Conversion
Orchard Therapeutics plc
Stock Option (Right to Buy)
2023-02-09−20,000→ 355,000 total
Exercise/Conversion
Orchard Therapeutics plc
Ordinary Shares
2023-02-09$0.46/sh+20,000→ 72,081 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2022-10-04−150,000→ 0 total
Award
Orchard Therapeutics plc
Stock Option (Right to Buy)
2022-10-04+310,000→ 310,000 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2022-10-04−426,185→ 0 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2022-10-04−310,000→ 0 total
Award
Orchard Therapeutics plc
Stock Option (Right to Buy)
2022-10-04+150,000→ 150,000 total
Award
Orchard Therapeutics plc
Stock Option (Right to Buy)
2022-10-04+27,731→ 27,731 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2022-10-04−184,229→ 0 total
Award
Orchard Therapeutics plc
Stock Option (Right to Buy)
2022-10-04+100,000→ 100,000 total
Award
Orchard Therapeutics plc
Stock Option (Right to Buy)
2022-10-04+200,000→ 200,000 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2022-10-04−27,731→ 0 total
Award
Orchard Therapeutics plc
Stock Option (Right to Buy)
2022-10-04+75,000→ 75,000 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2022-10-04−100,000→ 0 total
Award
Orchard Therapeutics plc
Stock Option (Right to Buy)
2022-10-04+426,185→ 426,185 total
Award
Orchard Therapeutics plc
Stock Option (Right to Buy)
2022-10-04+457,811→ 457,811 total
Award
Orchard Therapeutics plc
Stock Option (Right to Buy)
2022-10-04+184,229→ 184,229 total
Disposition to Issuer
Orchard Therapeutics plc
Stock Option (Right to Buy)
2022-10-04−200,000→ 0 total
Award
Spero Therapeutics, Inc.$SPRO
Common Stock
2022-09-15+15,000→ 15,000 total
Award
Orchard Therapeutics plc
Stock Option (Right to Buy)
2022-06-01+375,000→ 375,000 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (Right to Buy)
2022-05-10+8,300→ 8,300 total
Purchase
Orchard Therapeutics plc
Ordinary Shares
2022-04-01$0.75/sh+10,000→ 52,081 total
Award
Spero Therapeutics, Inc.$SPRO
Stock Option (Right to Buy)
2022-01-05$9.03/sh+2,214→ 2,214 total
Award
Spero Therapeutics, Inc.$SPRO
Stock Option (right to buy)
2021-08-17+7,500→ 7,500 total
Award
Larimar Therapeutics, Inc.$LRMR
Stock Option (right to buy)
2021-05-12+8,300→ 8,300 total
Award
Orchard Therapeutics plc
Stock Option (Right to Buy)
2021-02-01+310,000→ 310,000 total
Award
Orchard Therapeutics plc
Stock Option (Right to Buy)
2021-02-01+27,731→ 27,731 total

Companies

Recent Filings

Address

C/O LARIMAR THERAPEUTICS, INC. THREE BALA PLAZA EAST, SUITE 506

BALA CYNWYD, PA, 19004

View on SEC.gov